23 May 2013
Keywords: genentech, 3rd-qtr, income, climbs, sales, 9b, analysts
Article | 22 October 2007
\USA-based biotechnology firm Genentech, which is majority owned by Swiss drug major Roche, says that its net profit for the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 October 2007
26 November 2007
© 2013 thepharmaletter.com